NVIDIA BioNeMo Platform Secures Eli Lilly and Thermo Fisher Partnerships for AI Drug Discovery Infrastructure
NVIDIA's BioNeMo platform has secured partnerships with pharmaceutical giant Eli Lilly and laboratory supplier Thermo Fisher Scientific, positioning the company as infrastructure provider for AI-powered drug discovery globally. The platform provides pre-trained models for protein, DNA, and RNA research, with biotech startups across North America and Europe already building specialized applications on the system.
Salvado•